Provided by Tiger Trade Technology Pte. Ltd.

Plus Therapeutics, Inc.

3.87
0.0000
Volume:- -
Turnover:- -
Market Cap:26.56M
PE:-1.08
High:3.87
Open:3.87
Low:3.87
Close:3.87
52wk High:23.43
52wk Low:2.90
Shares:6.86M
Float Shares:6.46M
Volume Ratio:1.39
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.5690
EPS(LYR):-7.2500
ROE:-614.05%
ROA:-135.36%
PB:4.86
PE(LYR):-0.53

Loading ...

Feb 26, 2021

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Feb 26, 2021

[Rev.]Annual Report

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 26, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 26, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 23, 2021

Major Issues Report

8-K - Current report
Feb 22, 2021

Major Issues Report

8-K - Current report
Feb 22, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 10, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 29, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 12, 2021

Major Issues Report

8-K - Current report
Nov 03, 2020

Correspondence

CORRESP [Cover] - Correspondence
Oct 29, 2020

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Oct 23, 2020

Major Issues Report

8-K - Current report
Oct 22, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 22, 2020

Major Issues Report

8-K - Current report
Oct 15, 2020

Correspondence

CORRESP [Cover] - Correspondence
Oct 06, 2020

Major Issues Report

8-K - Current report
Oct 05, 2020

Major Issues Report

8-K - Current report
Sep 15, 2020

Major Issues Report

8-K - Current report
Aug 10, 2020

Major Issues Report

8-K - Current report